JP2015510916A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510916A5 JP2015510916A5 JP2015500892A JP2015500892A JP2015510916A5 JP 2015510916 A5 JP2015510916 A5 JP 2015510916A5 JP 2015500892 A JP2015500892 A JP 2015500892A JP 2015500892 A JP2015500892 A JP 2015500892A JP 2015510916 A5 JP2015510916 A5 JP 2015510916A5
- Authority
- JP
- Japan
- Prior art keywords
- cyanobenzoyl
- methylbenzamide
- pyrazol
- amino
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VGUSQKZDZHAAEE-UHFFFAOYSA-N 3-[5-amino-4-(3-cyanobenzoyl)pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide Chemical compound CC1=CC=C(C(=O)NC2CC2)C=C1N(C=1N)N=CC=1C(=O)C1=CC=CC(C#N)=C1 VGUSQKZDZHAAEE-UHFFFAOYSA-N 0.000 claims description 20
- 239000008194 pharmaceutical composition Substances 0.000 claims description 16
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 8
- 230000009798 acute exacerbation Effects 0.000 claims description 8
- -1 3-cyanobenzoyl Chemical group 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 6
- 239000012453 solvate Substances 0.000 claims 5
- 150000004677 hydrates Chemical class 0.000 claims 3
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 2
- YPCDNKNBOHKKHN-UHFFFAOYSA-N 2-cyclopropyl-4-methylbenzamide Chemical compound CC1=CC=C(C(N)=O)C(C2CC2)=C1 YPCDNKNBOHKKHN-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 3
- UHBGYFCCKRAEHA-UHFFFAOYSA-N P-toluamide Chemical compound CC1=CC=C(C(N)=O)C=C1 UHBGYFCCKRAEHA-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261613187P | 2012-03-20 | 2012-03-20 | |
| US61/613,187 | 2012-03-20 | ||
| PCT/EP2013/055730 WO2013139809A1 (en) | 2012-03-20 | 2013-03-19 | Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015510916A JP2015510916A (ja) | 2015-04-13 |
| JP2015510916A5 true JP2015510916A5 (enExample) | 2016-09-29 |
| JP6091593B2 JP6091593B2 (ja) | 2017-03-08 |
Family
ID=47901996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015500892A Active JP6091593B2 (ja) | 2012-03-20 | 2013-03-19 | 慢性閉塞性肺疾患の急性増悪の治療におけるピラゾール誘導体の使用 |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US9339491B2 (enExample) |
| EP (1) | EP2827860B1 (enExample) |
| JP (1) | JP6091593B2 (enExample) |
| KR (1) | KR101793777B1 (enExample) |
| CN (1) | CN104203234B (enExample) |
| AU (1) | AU2013237503B2 (enExample) |
| BR (1) | BR112014023107B1 (enExample) |
| CA (1) | CA2866108C (enExample) |
| CL (1) | CL2014002471A1 (enExample) |
| CY (1) | CY1118327T1 (enExample) |
| DK (1) | DK2827860T3 (enExample) |
| ES (1) | ES2605942T3 (enExample) |
| HR (1) | HRP20161514T1 (enExample) |
| HU (1) | HUE032004T2 (enExample) |
| IL (1) | IL234537A (enExample) |
| LT (1) | LT2827860T (enExample) |
| MA (1) | MA37455B1 (enExample) |
| MX (1) | MX351996B (enExample) |
| NZ (1) | NZ628392A (enExample) |
| PH (1) | PH12014502107B1 (enExample) |
| PL (1) | PL2827860T3 (enExample) |
| PT (1) | PT2827860T (enExample) |
| RU (1) | RU2625762C2 (enExample) |
| SG (1) | SG11201404941WA (enExample) |
| SI (1) | SI2827860T1 (enExample) |
| TN (1) | TN2014000350A1 (enExample) |
| TW (1) | TWI583381B (enExample) |
| WO (1) | WO2013139809A1 (enExample) |
| ZA (1) | ZA201405871B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2600833C1 (ru) * | 2015-09-03 | 2016-10-27 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГБУ "РНЦРХТ" Минздрава России) | Способ лечения хронической обструктивной болезни легких |
| RU2600822C1 (ru) * | 2015-09-03 | 2016-10-27 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГБУ "РНЦРХТ" Минздрава России) | Способ лечения хронического обструктивного бронхита |
| WO2017153702A1 (en) | 2016-03-08 | 2017-09-14 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| US10617674B2 (en) | 2016-03-08 | 2020-04-14 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of inflammatory conditions |
| US10331542B2 (en) * | 2016-06-23 | 2019-06-25 | International Business Machines Corporation | System and method for detecting and alerting unexpected behavior of software applications |
| GB201612238D0 (en) * | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
| GB201612240D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
| ES2927715T3 (es) | 2017-10-05 | 2022-11-10 | Fulcrum Therapeutics Inc | Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD |
| HUE054266T2 (hu) | 2017-12-11 | 2021-08-30 | Mereo Biopharma 1 Ltd | 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciklopropil-4-metilbenzamid alkalmazása krónikus obstruktív tüdõbetegség akut megjelenésének megelõzésében |
| KR102899004B1 (ko) * | 2017-12-11 | 2025-12-12 | 메레오 바이오파마 1 리미티드 | 만성 폐쇄성 폐 질환의 급성 악화의 치료에서의 3-[5-아미노-4-(3-시아노벤조일)-피라졸-1-일]-n-시클로프로필-4-메틸벤즈아미드의 용도 |
| CN114141383A (zh) * | 2021-12-17 | 2022-03-04 | 湖南大学 | 慢阻肺智能护理方法、装置及系统 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1832928B (zh) * | 2003-06-26 | 2012-07-04 | 诺瓦提斯公司 | 以5元杂环为基础的p38激酶抑制剂 |
| GB0603684D0 (en) * | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
-
2013
- 2013-03-19 ES ES13710851.0T patent/ES2605942T3/es active Active
- 2013-03-19 MX MX2014011291A patent/MX351996B/es active IP Right Grant
- 2013-03-19 JP JP2015500892A patent/JP6091593B2/ja active Active
- 2013-03-19 KR KR1020147025904A patent/KR101793777B1/ko active Active
- 2013-03-19 CA CA2866108A patent/CA2866108C/en active Active
- 2013-03-19 LT LTEP13710851.0T patent/LT2827860T/lt unknown
- 2013-03-19 PT PT137108510T patent/PT2827860T/pt unknown
- 2013-03-19 MA MA37455A patent/MA37455B1/fr unknown
- 2013-03-19 US US14/386,174 patent/US9339491B2/en active Active
- 2013-03-19 RU RU2014141893A patent/RU2625762C2/ru active
- 2013-03-19 HU HUE13710851A patent/HUE032004T2/en unknown
- 2013-03-19 TW TW102109739A patent/TWI583381B/zh active
- 2013-03-19 HR HRP20161514TT patent/HRP20161514T1/hr unknown
- 2013-03-19 PL PL13710851T patent/PL2827860T3/pl unknown
- 2013-03-19 EP EP13710851.0A patent/EP2827860B1/en active Active
- 2013-03-19 SI SI201330397A patent/SI2827860T1/sl unknown
- 2013-03-19 DK DK13710851.0T patent/DK2827860T3/en active
- 2013-03-19 CN CN201380015703.5A patent/CN104203234B/zh active Active
- 2013-03-19 BR BR112014023107-9A patent/BR112014023107B1/pt active IP Right Grant
- 2013-03-19 AU AU2013237503A patent/AU2013237503B2/en active Active
- 2013-03-19 SG SG11201404941WA patent/SG11201404941WA/en unknown
- 2013-03-19 WO PCT/EP2013/055730 patent/WO2013139809A1/en not_active Ceased
- 2013-03-19 NZ NZ628392A patent/NZ628392A/en unknown
-
2014
- 2014-08-11 TN TNP2014000350A patent/TN2014000350A1/fr unknown
- 2014-08-11 ZA ZA2014/05871A patent/ZA201405871B/en unknown
- 2014-09-08 IL IL234537A patent/IL234537A/en active IP Right Grant
- 2014-09-17 CL CL2014002471A patent/CL2014002471A1/es unknown
- 2014-09-22 PH PH12014502107A patent/PH12014502107B1/en unknown
-
2016
- 2016-04-29 US US15/143,356 patent/US20160243081A1/en not_active Abandoned
- 2016-11-18 CY CY20161101194T patent/CY1118327T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110036005A (zh) | 酰胺衍生物及其在药物中的应用 | |
| RU2018114447A (ru) | Введение дейтерированных усилителей cftr | |
| JP2016534063A5 (enExample) | ||
| JP2018534348A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2018162255A5 (enExample) | ||
| JP2016528301A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2016501221A5 (enExample) | ||
| JP2015091822A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| NZ628392A (en) | Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease | |
| JP2015523407A5 (enExample) | ||
| JP2020097577A5 (enExample) | ||
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| JP2016511753A5 (enExample) | ||
| JP2015511635A5 (enExample) | ||
| JP2018529742A5 (enExample) | ||
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| JP2017508817A5 (enExample) | ||
| RU2018146504A (ru) | Лечение внутрипеченочных холестатических заболеваний | |
| JP2021504384A5 (enExample) | ||
| JP2016516773A5 (enExample) | ||
| JP2017505809A5 (enExample) | ||
| JP2016530238A5 (enExample) |